Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,897 | 67 | 99.3% |
| Education | $13.52 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,400 | 51 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $182.05 | 4 | $0 (2024) |
| Novo Nordisk Inc | $124.90 | 1 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $59.48 | 3 | $0 (2024) |
| Almatica Pharma LLC | $49.96 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $35.06 | 2 | $0 (2023) |
| Indivior Inc. | $15.17 | 1 | $0 (2023) |
| Lundbeck LLC | $14.90 | 1 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $14.88 | 1 | $0 (2022) |
| Axsome Therapeutics, Inc. | $14.24 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $297.71 | 12 | ABBVIE INC. ($232.76) |
| 2023 | $1,428 | 52 | ABBVIE INC. ($1,168) |
| 2022 | $59.97 | 3 | IDORSIA PHARMACEUTICALS US INC ($23.55) |
| 2021 | $124.90 | 1 | Novo Nordisk Inc ($124.90) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.38 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.59 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.08 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.08 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Insomnia | ||||||
| 02/05/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: ANTI-ANXIETY | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.08 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Neuroscience | ||||||
| 01/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.62 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 41 | 148 | $34,526 | $8,318 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 75 | $21,641 | $5,221 | 24.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 20 | 73 | $12,885 | $3,097 | 24.0% |
About Lied Metcalf
Lied Metcalf is a Psychiatric/Mental Health healthcare provider based in Wadesboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2012. The National Provider Identifier (NPI) number assigned to this provider is 1497025571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lied Metcalf has received a total of $1,911 in payments from pharmaceutical and medical device companies, with $297.71 received in 2024. These payments were reported across 68 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,897).
As a Medicare-enrolled provider, Metcalf has provided services to 41 Medicare beneficiaries, totaling 148 services with total Medicare billing of $8,318. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Registered Nurse
- Location Wadesboro, NC
- Active Since 01/06/2012
- Last Updated 02/05/2026
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497025571
Products in Payments
- VRAYLAR (Drug) $1,400
- SPRAVATO (Drug) $182.05
- RYBELSUS (Drug) $124.90
- QUVIVIQ (Drug) $59.48
- LOREEV XR (Drug) $49.96
- REXULTI (Drug) $49.96
- SUBLOCADE (Drug) $15.17
- INGREZZA (Drug) $14.88
- Auvelity (Drug) $14.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.